These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

986 related items for PubMed ID: 29976228

  • 1. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E, Berens-Riha N, Pritsch M, Nwachuku N, Loescher T, Meremikwu M.
    Malar J; 2018 Jul 06; 17(1):251. PubMed ID: 29976228
    [Abstract] [Full Text] [Related]

  • 2. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
    Tagbor H, Cairns M, Bojang K, Coulibaly SO, Kayentao K, Williams J, Abubakar I, Akor F, Mohammed K, Bationo R, Dabira E, Soulama A, Djimdé M, Guirou E, Awine T, Quaye S, Njie F, Ordi J, Doumbo O, Hodgson A, Oduro A, Meshnick S, Taylor S, Magnussen P, ter Kuile F, Woukeu A, Milligan P, Chandramohan D, Greenwood B.
    PLoS One; 2015 Jul 06; 10(8):e0132247. PubMed ID: 26258474
    [Abstract] [Full Text] [Related]

  • 3. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
    Madanitsa M, Kalilani L, Mwapasa V, van Eijk AM, Khairallah C, Ali D, Pace C, Smedley J, Thwai KL, Levitt B, Wang D, Kang'ombe A, Faragher B, Taylor SM, Meshnick S, Ter Kuile FO.
    PLoS Med; 2016 Sep 06; 13(9):e1002124. PubMed ID: 27622558
    [Abstract] [Full Text] [Related]

  • 4. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.
    Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D.
    PLoS One; 2010 Dec 28; 5(12):e14425. PubMed ID: 21203389
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
    Natama HM, Toussaint R, Bazié DLC, Samadoulougou S, Coulibaly-Traoré M, Tinto H, Kirakoya-Samadoulougou F.
    Malar J; 2020 Nov 10; 19(1):399. PubMed ID: 33172485
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, Wiegand RE, Filler SJ, Kamuliwo M, Craig AS, Tan KR.
    Malar J; 2015 Feb 07; 14():69. PubMed ID: 25890159
    [Abstract] [Full Text] [Related]

  • 7. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, Moutandou Chiesa S, Tshibola Mbuyi ML, Tsoumbou-Bakana G, Zong J, Ambounda N, Kombila M.
    Trans R Soc Trop Med Hyg; 2016 Jun 07; 110(6):333-42. PubMed ID: 27268713
    [Abstract] [Full Text] [Related]

  • 8. Mefloquine for preventing malaria in pregnant women.
    González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C.
    Cochrane Database Syst Rev; 2018 Mar 21; 3(3):CD011444. PubMed ID: 29561063
    [Abstract] [Full Text] [Related]

  • 9. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
    COSMIC Consortium.
    Clin Infect Dis; 2019 Feb 01; 68(4):586-596. PubMed ID: 29961848
    [Abstract] [Full Text] [Related]

  • 10. The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine.
    Awine T, Belko MM, Oduro AR, Oyakhirome S, Tagbor H, Chandramohan D, Milligan P, Cairns M, Greenwood B, Williams JE.
    Malar J; 2016 Jan 28; 15():46. PubMed ID: 26821532
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
    Kimani J, Phiri K, Kamiza S, Duparc S, Ayoub A, Rojo R, Robbins J, Orrico R, Vandenbroucke P.
    PLoS One; 2016 Jan 28; 11(6):e0157045. PubMed ID: 27326859
    [Abstract] [Full Text] [Related]

  • 12. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I, Tinto H, Drabo MK, Huybregts L, Henry MC, Roberfroid D, Guiguemde RT, Kolsteren P, D'Alessandro U, FSP/MISAME study Group.
    Malar J; 2010 Nov 12; 9():324. PubMed ID: 24576068
    [Abstract] [Full Text] [Related]

  • 13. Mefloquine for preventing malaria in pregnant women.
    González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C.
    Cochrane Database Syst Rev; 2018 Nov 14; 11(11):CD011444. PubMed ID: 30480761
    [Abstract] [Full Text] [Related]

  • 14. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ, Thigpen MC, Parise ME, Newman RD.
    Drug Saf; 2007 Nov 14; 30(6):481-501. PubMed ID: 17536875
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D, Chilongola J, Ndeserua R, Mwingira F, Genton B.
    Trop Med Int Health; 2014 Sep 14; 19(9):1048-56. PubMed ID: 24965022
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
    Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL.
    Ann Trop Med Parasitol; 1998 Mar 14; 92(2):141-50. PubMed ID: 9625909
    [Abstract] [Full Text] [Related]

  • 17. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP, Minzi O, Mutagonda R, Baraka V, Mlugu EM, Aklillu E, Kamuhabwa AAR.
    Malar J; 2020 Apr 19; 19(1):160. PubMed ID: 32306955
    [Abstract] [Full Text] [Related]

  • 18. Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
    Taylor SM, Levitt B, Freedman B, Madanitsa M, Thwai KL, Kalilani-Phiri L, Khairallah C, Mwapasa V, Ter Kuile FO, Meshnick SR.
    J Infect Dis; 2020 Jul 23; 222(4):661-669. PubMed ID: 32221555
    [Abstract] [Full Text] [Related]

  • 19. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J, Ouma P, Oluoch S, Bruce J, Kariuki S, Desai M, Webster J.
    Malar J; 2020 Nov 25; 19(1):433. PubMed ID: 33238999
    [Abstract] [Full Text] [Related]

  • 20. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S, Coulibaly SO, Ouattara FT, D'Alessandro U.
    Trop Med Int Health; 2009 Feb 25; 14(2):174-82. PubMed ID: 19171009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.